Stories
Zydus Lifesciences Ahmedabad Plant Receives Five Observations from USFDA
C
CNBC TV18•13-10-2026, 20:55
Zydus Lifesciences Ahmedabad Plant Receives Five Observations from USFDA
- •The US Food and Drug Administration conducted an inspection at Zydus Lifesciences manufacturing plant in Moraiya, Ahmedabad, from October 5 to October 13, 2026.
- •The inspection concluded with five observations, and the company stated it will work closely with the USFDA to address them expeditiously.
- •Zydus Lifesciences reported a 22 percent increase in revenue to ₹8,017 crore for the first quarter, alongside strong performance in its India branded formulations business.
Key Questions Answered
The US Food and Drug Administration inspection at Zydus Lifesciences' manufacturing plant in Moraiya, Ahmedabad, concluded with five observations.
The USFDA inspection at the manufacturing facility located in Moraiya, Ahmedabad, was conducted from October 5 to October 13, 2026.
In the first quarter, Zydus Lifesciences reported a 22% increase in revenue to ₹8,017 crore, while its EBITDA declined 7.6% to ₹1,929.4 crore compared to the previous fiscal year.
